Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001687888-18-000001
Filing Date
2018-07-27
Accepted
2018-07-27 09:54:33
Documents
1
Period of Report
2018-07-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2815
  Complete submission text file 0001687888-18-000001.txt   4412
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2110 RANCH ROAD 620 S LAKEWAY TX 78734
Business Address 2110 RANCH ROAD 620 S LAKEWAY TX 78734 5212150510
JFL Capital Management, LLC (Reporting) CIK: 0001687888 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 18973530